Equity Profile

IDXX

IDEXX Laboratories, Inc.

Health CareHealth Care Equipment$44.7B

Aug3Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of diagnostic tests and services for the veterinary, livestock, and poultry industries....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance.

$3.93

Revenue

Total revenue reflects the overall sales performance and market demand for IDEXX's products.

$1.2B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IDXX Q2-2026 Earnings Preview

Context

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of diagnostic tests and services for the veterinary, livestock, and poultry industries. As part of the Health Care sector, IDEXX plays a crucial role in animal health, leveraging technology and innovation to improve diagnostic accuracy and efficiency.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.46%

Avg Stock Reaction

+6.39%

Last Quarter Recap

In Q1-2026, IDEXX reported an EPS of $3.47, beating estimates by 1.49%. The stock had a slight decline of 0.03% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IDEXX to report strong earnings, with a consensus EPS of $3.93. Investors are closely watching for any signs of growth in revenue and profitability.

Bull Case

If IDEXX exceeds the EPS estimate, it could signal strong demand for its products, potentially leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about market demand and future growth, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$3.93

Earnings per share is a key indicator of the company's profitability and performance.

Revenue

$1.2B

Total revenue reflects the overall sales performance and market demand for IDEXX's products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $3.93?

A strong EPS could indicate robust demand and operational efficiency, positively influencing investor sentiment.

What insights can management provide regarding revenue growth trends?

Understanding revenue dynamics will be crucial for assessing the company's future growth prospects and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate IDEXX's ability to capitalize on emerging trends in animal health diagnostics, particularly in the face of increasing pet ownership.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with a 75% success rate over the last eight quarters.

Options pricing suggests a significant move, indicating that investors are anticipating volatility and potential surprises.

Recent trends in pet ownership and veterinary spending may not be fully reflected in current revenue estimates.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized to gauge IDEXX's growth trajectory and market health.

Bull Confirmed If

An EPS of $4.00 or higher would confirm strong operational performance and demand.

Bear Confirmed If

An EPS below $3.81 could signal weakening demand and operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±17.90%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings announcement.

Options are pricing ±17.9% while IDXX has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

31.3%

Calls (3K)P/C Ratio: 2.14Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IDEXX beats expectations, history suggests a potential stock increase of around 8.77%, confirming strong demand.

In-Line / Cautious

An in-line report could lead to muted reactions, as investors await further guidance on future growth.

Miss

If the company misses expectations, history indicates a likely decline of about 0.73%, raising concerns about market demand.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic technology.
2Management's commentary on market trends and competitive positioning.
3Insights into customer demand and sales performance in key markets.
4Discussion of cost management strategies and their impact on margins.
5Any guidance on future revenue expectations and growth initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul31

SONYBMO

Sony Group Corporation

PreviewView

Jul31

ENBBMO

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of diagnostic tests and services for the veterinary, livestock, and poultry industries....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and performance.

$3.93

Revenue

Total revenue reflects the overall sales performance and market demand for IDEXX's products.

$1.2B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IDXX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.46%

Avg Stock Reaction

+6.39%

Last Quarter Recap

In Q1-2026, IDEXX reported an EPS of $3.47, beating estimates by 1.49%. The stock had a slight decline of 0.03% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IDEXX to report strong earnings, with a consensus EPS of $3.93. Investors are closely watching for any signs of growth in revenue and profitability.

Bull Case

If IDEXX exceeds the EPS estimate, it could signal strong demand for its products, potentially leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about market demand and future growth, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$3.93

Earnings per share is a key indicator of the company's profitability and performance.

Revenue

$1.2B

Total revenue reflects the overall sales performance and market demand for IDEXX's products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $3.93?

A strong EPS could indicate robust demand and operational efficiency, positively influencing investor sentiment.

What insights can management provide regarding revenue growth trends?

Understanding revenue dynamics will be crucial for assessing the company's future growth prospects and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate IDEXX's ability to capitalize on emerging trends in animal health diagnostics, particularly in the face of increasing pet ownership.

Supporting Evidence

The company has a strong track record of beating EPS estimates, with a 75% success rate over the last eight quarters.

Options pricing suggests a significant move, indicating that investors are anticipating volatility and potential surprises.

Recent trends in pet ownership and veterinary spending may not be fully reflected in current revenue estimates.

Key Risk

If revenue growth significantly outpaces expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized to gauge IDEXX's growth trajectory and market health.

Bull Confirmed If

An EPS of $4.00 or higher would confirm strong operational performance and demand.

Bear Confirmed If

An EPS below $3.81 could signal weakening demand and operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±17.90%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings announcement.

Options are pricing ±17.9% while IDXX has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

31.3%

Calls (3K)P/C Ratio: 2.14Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IDEXX beats expectations, history suggests a potential stock increase of around 8.77%, confirming strong demand.

In-Line / Cautious

An in-line report could lead to muted reactions, as investors await further guidance on future growth.

Miss

If the company misses expectations, history indicates a likely decline of about 0.73%, raising concerns about market demand.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic technology.
2Management's commentary on market trends and competitive positioning.
3Insights into customer demand and sales performance in key markets.
4Discussion of cost management strategies and their impact on margins.
5Any guidance on future revenue expectations and growth initiatives.